Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Varticovski Website

Lyuba Varticovski, M.D.

Selected Publications

1)  Hager GL, Varticovski L.
Chromatin in time and space.
Biochim. Biophys. Acta. 1819: 631, 2012.
2)  Stavreva DA, Varticovski L, Hager GL.
Complex dynamics of transcription regulation.
Biochim. Biophys. Acta. 1819: 657-66, 2012.
3)  Dunlap SM, Chiao LJ, Nogueira L, Usary J, Perou CM, Varticovski L, Hursting SD.
Dietary Energy Balance Modulates Epithelial-to-Mesenchymal Transition and Tumor Progression in Murine Claudin-Low and Basal-like Mammary Tumor Models.
Cancer Prev Res (Phila). 5: 930-42, 2012.
4)  Kon M, Kiffin R, Koga H, Chapochnick J, Macian F, Varticovski L, Cuervo AM.
Chaperone-mediated autophagy is required for tumor growth.
Sci Transl Med. 3: 109ra117, 2011.
5)  Luchenko VL, Salcido CD, Zhang Y, Agama K, Komlodi-Pasztor E, Murphy RF, Giaccone G, Pommier Y, Bates SE, Varticovski L.
Schedule-dependent synergy of histone deacetylase inhibitors with DNA damaging agents in small cell lung cancer.
Cell Cycle. 10: 3119-28, 2011.
6)  Salcido CD, Larochelle A, Taylor BJ, Dunbar CE, Varticovski L.
Molecular characterisation of side population cells with cancer stem cell-like characteristics in small-cell lung cancer.
Br. J. Cancer. 102: 1636-44, 2010.
7)  Calcagno AM, Salcido CD, Gillet JP, Wu CP, Fostel JM, Mumau MD, Gottesman MM, Varticovski L, Ambudkar SV.
Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.
J. Natl. Cancer Inst. 102: 1637-52, 2010.
8)  Ghobrial IM, Roccaro A, Hong F, Weller E, Rubin N, Leduc R, Rourke M, Chuma S, Sacco A, Jia X, Azab F, Azab AK, Rodig S, Warren D, Harris B, Varticovski L, Sportelli P, Leleu X, Anderson KC, Richardson PG.
Clinical and translational studies of a phase II trial of the novel oral Akt inhibitor perifosine in relapsed or relapsed/refractory Waldenstrom's macroglobulinemia.
Clin. Cancer Res. 16: 1033-41, 2010.
9)  Cerchietti LC, Lopes EC, Yang SN, Hatzi K, Bunting KL, Tsikitas LA, Mallik A, Robles AI, Walling J, Varticovski L, Shaknovich R, Bhalla KN, Chiosis G, Melnick A.
A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas.
Nat. Med. 15: 1369-76, 2009.
10)  Pine SR, Ryan BM, Varticovski L, Robles AI, Harris CC.
Microenvironmental modulation of asymmetric cell division in human lung cancer cells.
Proc. Natl. Acad. Sci. U.S.A. 107: 2195-200, 2010.
Click Here to View Expanded Bibliography.

This page was last updated on 7/22/2012.